205 related articles for article (PubMed ID: 30951294)
1. Anticancer Drug Affects Metabolomic Profiles in Multicellular Spheroids: Studies Using Mass Spectrometry Imaging Combined with Machine Learning.
Tian X; Zhang G; Zou Z; Yang Z
Anal Chem; 2019 May; 91(9):5802-5809. PubMed ID: 30951294
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of therapeutics in three-dimensional cell culture systems by MALDI imaging mass spectrometry.
Liu X; Weaver EM; Hummon AB
Anal Chem; 2013 Jul; 85(13):6295-302. PubMed ID: 23724927
[TBL] [Abstract][Full Text] [Related]
3. Towards enhanced metabolomic data analysis of mass spectrometry image: Multivariate Curve Resolution and Machine Learning.
Tian X; Zhang G; Shao Y; Yang Z
Anal Chim Acta; 2018 Dec; 1037():211-219. PubMed ID: 30292295
[TBL] [Abstract][Full Text] [Related]
4. iTRAQ Quantitative Proteomic Profiling and MALDI-MSI of Colon Cancer Spheroids Treated with Combination Chemotherapies in a 3D Printed Fluidic Device.
LaBonia GJ; Ludwig KR; Mousseau CB; Hummon AB
Anal Chem; 2018 Jan; 90(2):1423-1430. PubMed ID: 29227110
[TBL] [Abstract][Full Text] [Related]
5. Spatially resolved metabolomics combined with multicellular tumor spheroids to discover cancer tissue relevant metabolic signatures.
Zang Q; Sun C; Chu X; Li L; Gan W; Zhao Z; Song Y; He J; Zhang R; Abliz Z
Anal Chim Acta; 2021 Apr; 1155():338342. PubMed ID: 33766316
[TBL] [Abstract][Full Text] [Related]
6. Mass Spectrometry Imaging Combined with Metabolomics Revealing the Proliferative Effect of Environmental Pollutants on Multicellular Tumor Spheroids.
Xie P; Liang X; Song Y; Cai Z
Anal Chem; 2020 Aug; 92(16):11341-11348. PubMed ID: 32668148
[TBL] [Abstract][Full Text] [Related]
7. Microscale Mass Spectrometry Analysis of Extracellular Metabolites in Live Multicellular Tumor Spheroids.
Sun M; Tian X; Yang Z
Anal Chem; 2017 Sep; 89(17):9069-9076. PubMed ID: 28753268
[TBL] [Abstract][Full Text] [Related]
8. Drug penetration and metabolism in 3D cell cultures treated in a 3D printed fluidic device: assessment of irinotecan via MALDI imaging mass spectrometry.
LaBonia GJ; Lockwood SY; Heller AA; Spence DM; Hummon AB
Proteomics; 2016 Jun; 16(11-12):1814-21. PubMed ID: 27198560
[TBL] [Abstract][Full Text] [Related]
9. Use of physiological information based on grayscale images to improve mass spectrometry imaging data analysis from biological tissues.
Mas S; Torro A; Bec N; Fernández L; Erschov G; Gongora C; Larroque C; Martineau P; de Juan A; Marco S
Anal Chim Acta; 2019 Oct; 1074():69-79. PubMed ID: 31159941
[TBL] [Abstract][Full Text] [Related]
10. Quantitative Assessment of Anti-Cancer Drug Efficacy From Coregistered Mass Spectrometry and Fluorescence Microscopy Images of Multicellular Tumor Spheroids.
Michálek J; Štěpka K; Kozubek M; Navrátilová J; Pavlatovská B; Machálková M; Preisler J; Pruška A
Microsc Microanal; 2019 Dec; 25(6):1311-1322. PubMed ID: 31571549
[TBL] [Abstract][Full Text] [Related]
11. MALDI Mass Spectrometry Imaging for Evaluation of Therapeutics in Colorectal Tumor Organoids.
Liu X; Flinders C; Mumenthaler SM; Hummon AB
J Am Soc Mass Spectrom; 2018 Mar; 29(3):516-526. PubMed ID: 29209911
[TBL] [Abstract][Full Text] [Related]
12. Mass spectrometry imaging revealed alterations of lipid metabolites in multicellular tumor spheroids in response to hydroxychloroquine.
Chen Y; Wang T; Xie P; Song Y; Wang J; Cai Z
Anal Chim Acta; 2021 Nov; 1184():339011. PubMed ID: 34625248
[TBL] [Abstract][Full Text] [Related]
13. Quantification of Irinotecan in Single Spheroids Using Internal Standards by MALDI Mass Spectrometry Imaging.
Wang Y; Hummon AB
Anal Chem; 2023 Jun; 95(24):9227-9236. PubMed ID: 37285205
[TBL] [Abstract][Full Text] [Related]
14. How to Apply Supervised Machine Learning Tools to MS Imaging Files: Case Study with Cancer Spheroids Undergoing Treatment with the Monoclonal Antibody Cetuximab.
Hua D; Liu X; Go EP; Wang Y; Hummon AB; Desaire H
J Am Soc Mass Spectrom; 2020 Jul; 31(7):1350-1357. PubMed ID: 32469221
[TBL] [Abstract][Full Text] [Related]
15. Matrix Assisted Laser Desorption/Ionization Mass Spectrometry Imaging (MALDI MSI) for Monitoring of Drug Response in Primary Cancer Spheroids.
Mittal P; Price ZK; Lokman NA; Ricciardelli C; Oehler MK; Klingler-Hoffmann M; Hoffmann P
Proteomics; 2019 Nov; 19(21-22):e1900146. PubMed ID: 31474002
[TBL] [Abstract][Full Text] [Related]
16. Extract Metabolomic Information from Mass Spectrometry Images Using Advanced Data Analysis.
Tian X; Zou Z; Yang Z
Methods Mol Biol; 2022; 2437():253-272. PubMed ID: 34902154
[TBL] [Abstract][Full Text] [Related]
17. The Future in Disease Models for Mass Spectrometry Imaging, Ethical Issues, and the Way Forward.
Day RE; Palubeckaite I
Methods Mol Biol; 2017; 1618():191-201. PubMed ID: 28523509
[TBL] [Abstract][Full Text] [Related]
18. Mass spectrometry imaging of endogenous metabolites in response to doxorubicin in a novel 3D osteosarcoma cell culture model.
Palubeckaitė I; Crooks L; Smith DP; Cole LM; Bram H; Le Maitre C; Clench MR; Cross NA
J Mass Spectrom; 2020 Apr; 55(4):e4461. PubMed ID: 31654532
[TBL] [Abstract][Full Text] [Related]
19. Towards early monitoring of chemotherapy-induced drug resistance based on single cell metabolomics: Combining single-probe mass spectrometry with machine learning.
Liu R; Sun M; Zhang G; Lan Y; Yang Z
Anal Chim Acta; 2019 Dec; 1092():42-48. PubMed ID: 31708031
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
